CXCL8 and chronic myelogenous leukemia, BCR-ABL1 positive: underlined that EVs released from CML cells could affect ECs directly by inducing their release of proangiogenic cytokines, such as IL8, thus modulating neovascularization, which plays an important role in the development and progression of CML (35).